Recent social media discussions have highlighted concerns about the pain associated with intrauterine device (IUD) insertion, with many individuals sharing experiences where their pain was dismissed or underestimated by healthcare providers.These accounts often describe inadequate pain management, such as relying solely on over-the-counter ibuprofen, leading to calls for improved protocols.

In response to these concerns, the Centers for Disease Control and Prevention (CDC) issued updated recommendations for providers last year. The CDC acknowledged that lidocaine, a topical anesthetic, “might be useful” during IUD placement. While not a definitive endorsement of pain management, the guidance advised providers to counsel patients about available pain relief options before the procedure, marking a significant change in practice.

ACOG Acknowledges Underestimation of Pain

The American College of obstetricians and Gynecologists (ACOG) is now expanding on these advancements with new guidance on pain management for procedures like IUD insertion and biopsies. ACOG acknowledges that providers frequently enough underestimate the pain patients feel during their procedures. The institution says ther is “an urgent need for health care professionals to have a better understanding of pain-management options.”

“An urgent need for health care professionals to have a better understanding of pain-management options.”

The new ACOG guidelines discuss various pain management strategies, including lidocaine sprays, creams, and injections, as well as the use of anti-inflammatory drugs like ibuprofen before procedures. The effectiveness of each strategy can vary depending on the specific procedure, with LEEP and hysterotomy procedures typically causing more pain than IUD insertion. individual pain tolerance also plays a significant role. The most crucial aspect of the updated guidance is the suggestion that all patients receive comprehensive counseling about available pain management options.